Get started

Osaka Prefectural Hospital Organization

Homepage: opho.jp
Alternate name: 大阪府立病院機構
ROR: 00fb90w44
OpenAlex ID: I4405282797
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
2018 · Lorenzo Galluzzi, Ilio Vitale, et al. · Cell Death and Differentiation · 7,055
PDF
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
2017 · Jean-Charles Soria, Yuichiro Ohe, et al. · New England Journal of Medicine · 5,649
PDF
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
1998 · Seiichi Hirota, Koji Isozaki, et al. · Science · 4,509
The repertoire of mutational signatures in human cancer
2020 · Ludmil B. Alexandrov, Jaegil Kim, et al. · Nature · 3,619
PDF
Pan-cancer analysis of whole genomes
2020 · Lauri A. Aaltonen, Federico Abascal, et al. · Nature · 3,075
PDF
Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
2019 · Suresh S. Ramalingam, Johan Vansteenkiste, et al. · New England Journal of Medicine · 3,012
PDF
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
2021 · Daniel J. Klionsky, Amal Kamal Abdel-Aziz, et al. · Autophagy · 2,955
PDF
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
2019 · Christina Fitzmaurice, Degu Abate, et al. · JAMA Oncology · 2,582
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
2017 · John W. Eikelboom, Stuart J. Connolly, et al. · New England Journal of Medicine · 2,516
PDF
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
2014 · Hansjochen Wilke, Kei Muro, et al. · The Lancet Oncology · 2,498
A cross-population atlas of genetic associations for 220 human phenotypes
2021 · Saori Sakaue, Masahiro Kanai, et al. · Nature Genetics · 2,390
Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
1996 · Takashi Nagasawa, Seiichi Hirota, et al. · Nature · 2,382
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
2009 · Marta Pàez-Ribes, Elizabeth Allen, et al. · Cancer Cell · 2,377
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
2021 · Jonathan M. Kocarnik, Kelly Compton, et al. · JAMA Oncology · 2,209
PDF
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
2008 · Wasaburo Koizumi, Hiroyuki Narahara, et al. · The Lancet Oncology · 1,858
Segmentectomy Versus Lobectomy in Small-Sized Peripheral Non-Small Cell Lung Cancer (JCOG0802/WJOG4607L): A Multicentre, Randomised, Controlled, Phase 3 Trial
2021 · Hisashi Saji, Morihito Okada, et al. · The Lancet · 1,819
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
1998 · Qing Ma, Dan Jones, et al. · Proceedings of the National Academy of Sciences · 1,720
Essential role of Stat6 in IL-4 signalling
1996 · Kiyoshi Takeda, Takashi Tanaka, et al. · Nature · 1,561
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
1998 · Kazunobu Tachibana, Seiichi Hirota, et al. · Nature · 1,548
Cancer survival in five continents: a worldwide population-based study (CONCORD)
2008 · Michel P Coleman, Manuela Quaresma, et al. · The Lancet Oncology · 1,525
PDF
Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
1999 · Kiyoyuki Furuse, Masahiro Fukuoka, et al. · Journal of Clinical Oncology · 1,492
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
2020 · Kohei Shitara, Yung-Jue Bang, et al. · New England Journal of Medicine · 1,377
PDF
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
1997 · Kiyoshi Takeda, Koichi Noguchi, et al. · Proceedings of the National Academy of Sciences · 1,331
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
2022 · Do-Youn Oh, Aiwu Ruth He, et al. · NEJM Evidence · 1,320
TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction
2003 · Hiroyuki Oshiumi, Misako Matsumoto, et al. · Nature Immunology · 1,218
Works count: 501
Works count with child institutions: 17,350
Citation count: 17,530
Year
Topic
Type